Hematologic Cancer Diagnostics Market

добавлена новая статья Другое

2026-02-13 08:33:21 -

Hematologic Cancer Diagnostics Market – MM Segment

According to FutureWise analysis the market for Multiple Myeloma Diagnostics in 2026 is US$ 15.07 billion, and is expected to reach US$ 33.19 billion by 2036 at a CAGR of 8.22%. Market growth is driven by the rising incidence of hematologic malignancies and the adoption of advanced diagnostic technologies such as flow cytometry and next-generation sequencing. Increased awareness, early...

0 Комментарии 0 Поделились 444 Просмотры 0 предпросмотр